Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06463262 · ClinicalTrials.gov registry record
Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma
A clinical trial of Chordoma of Spine and Chordoma of Sacrum, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Recruiting
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT06463262 is a study of Chordoma of Spine and Chordoma of Sacrum that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 40 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06463262, a study of Chordoma of Spine and Chordoma of Sacrum, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study the investigators will study the effects of neoadjuvant radiation therapy (RT), in the form of either proton therapy or stereotactic body radiation therapy (SBRT), on the Circulating tumor DNA (ctDNA), radiographic changes and radiomics, and the validity of these findings will be compared using the current gold standard- pathologic findings. The purpose of this work is to explore whether the biomarkers may be used diagnostically to better understand radiographic changes following RT. The investigators hypothesize that ctDNA levels in combination with imaging biomarkers identified through radiomics will be a sensitive and specific tool for predicting histopathologic response to RT.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST ctDNA
Study Locations (2)
Maryland
- Johns Hopkins Hospital - Baltimore
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2031-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06463262
The ClinicalTrials.gov registry entry for NCT06463262 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chordoma of Spine appearing as the primary indexed condition, and to 1 intervention - of which ctDNA is the first listed.
NCT06463262 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06463262 about?
NCT06463262 is a clinical study titled "Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma". In this study the investigators will study the effects of neoadjuvant radiation therapy (RT), in the form of either proton therapy or stereotactic body radiation therapy (SBRT), on the Circulating tumor DNA (ctDNA), radiographic changes and radiomics, and the validity of these findings will be compa...
What is the current status of trial NCT06463262?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-06-14. Estimated completion is 2031-07.
What conditions does trial NCT06463262 study?
This clinical trial studies the following conditions: Chordoma of Spine, Chordoma of Sacrum, Chordoma of Skull Base.
What interventions are being tested in trial NCT06463262?
The interventions under investigation include: ctDNA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06463262?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06463262 being conducted?
This trial has 2 study locations across Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chordoma of Spine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.